ALBIO — Biosynex SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €40.99m
- €71.47m
- €196.59m
- 40
- 77
- 13
- 35
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ||
Standards: | — | — | FAS | FAS | FAS |
Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
Net Income/Starting Line | — | — | 31.4 | 107 | 15.6 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | — | — | 0.001 | 0.031 | -0.008 |
Unusual Items | |||||
Changes in Working Capital | — | — | -7.18 | 0.578 | -37.3 |
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | — | — | 31.6 | 110 | 4.95 |
Capital Expenditures | — | — | -9.12 | -19 | -30.1 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | 1.19 | -9.95 | -9 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | — | -7.93 | -29 | -39.1 |
Financing Cash Flow Items | — | — | 0.154 | -1.78 | -21.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | — | — | 10.6 | 14.4 | -10.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | — | — | 34.3 | 95.3 | -45 |